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New Urea-Absorbing Polymers for Artificial Kidney Machines 
.
The problem: 
One of the goals in the development of a small 
inexpensive artificial kidney is an efficient way of 
removing urea from the dialyzing fluid. Activated 
charcoal can adsorb from 0.2 to 0.8 gram of urea per 
100 grams of carbon. Enzyme decomposition of urea 
followed by treatment with sodium zirconium 
phosphate to remove the evolved ammonia extracts 
about 2 grams of urea per 100 grams of phosphate. 
There is a need for better absorbents if dialysis devices 
are to be made small enough to be portable. 
The solution: 
A new urea-absorbing polymer has been synthe-
sized from polysaccharides which are either etherified 
or cross linked. 
How it's done: 
The etherified polymer is made from a modified 
cellulose derivative which is then reacted with 
periodate. It will absorb 2 grams of urea per 100 
grams of polymer. The cross-linked polymer is 
prepared from a modified oxidized starch which is 
cross linked with isocyanates to form urethane 
copolymers or is cross linked with carboxylic acids to 
form ester copolymers. Other cross-linking com-
pounds may also be used. After post treatment and 
purification, 100 grams of the polymers can absorb 
6.5 grams of urea at room temperature and pH 2.
The absorption occurs because aldehyde groups, in 
the cagelike structure formed by the polymer 
cross-links, have an affinity for urea molecules. 
Indications are that the polymers could be packed in a 
column to help remove uremic wastes in artificial 
kidneys, or they could be administered orally as 
therapy for uremia. [Also see NASA Tech Brief 
B75-10327 (NPO-13487)]. 
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